George A. Scangos, Director at Vir Biotechnology, Inc. (VIR), sold 21,928 shares at $9.81 ($215K) on 2025-02-18, disclosed to the SEC on 2025-02-19.
Scheduled sale ($215k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.81 | 10,964 | $108K | 50.0% |
| 2 | $9.81 | 10,964 | $108K | 50.0% |
| Total | $9.81 avg | 21,928 | $215K | 100% |
| Filing → |
| VIR | SELL | 2024-02-20 | $568K | — | Filing → |
| VIR | SELL | 2023-02-24 | $1.4M | — | Filing → |
| VIR | SELL | 2023-02-21 | $1.5M | — | Filing → |